Loading insider details...
Beta
Latest Form 4 (Jun 23, 2026): Grant/Award of 6,212 IRON shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 23, 2026 | Disc Medicine, Inc. (IRON) | Grant/Award | 6,212 | n/a |
| Mar 4, 2026 | Ventyx Biosciences, Inc. (VTYX) | Disposition to Issuer | 33,000 | n/a |
| Dec 9, 2025 | Akero Therapeutics, Inc. (AKRO) | Disposition to Issuer | 10,179 | n/a |
| Sep 13, 2025 | Akero Therapeutics, Inc. (AKRO) | Sale | 659 | $28.4K |
| Jul 2, 2025 | Akero Therapeutics, Inc. (AKRO) | Grant/Award | 890 | $21.2K |
| Jun 21, 2025 | Akero Therapeutics, Inc. (AKRO) | Sale | 1,634 | $89.6K |
| Jun 13, 2025 | Disc Medicine, Inc. (IRON) | Grant/Award | 10,000 | n/a |
| Jun 12, 2025 | Akero Therapeutics, Inc. (AKRO) | Sale | 2,804 | $151.4K |
| Jun 6, 2025 | Ventyx Biosciences, Inc. (VTYX) | Grant/Award | 40,000 | n/a |
| Mar 15, 2025 | Akero Therapeutics, Inc. (AKRO) | Sale | 676 | $30.3K |